[Administration of ranitidine once in the evening for several weeks: effect on acidity and basal hormone levels in normal subjects]. 1985

P Müller, and H G Dammann, and B Simon

The effects of ranitidine (300 mg at night) on gastric acid secretion as well as on basal hormone levels (testosterone, prolactin, dehydro-epiandrosterone etc.) were assessed in 9 healthy volunteers before, during and after a 28-day treatment. On day 29, i.e. 12 h after the last ranitidine dose, basal and stimulated acid secretion was only slightly reduced by some 14 and 12%, respectively. On day 35, gastric acid output had returned to pretreatment values. There were no signs of a rebound phenomenon. Basal levels of prolactin, testosterone, dehydroepiandrosterone etc. were unchanged by 28-day ranitidine treatment. Ranitidine 300 mg at night may, therefore, be used in the treatment of peptic ulcer disease without any negative effect on human gastric acid secretion and basal hormone levels.

UI MeSH Term Description Entries
D008297 Male Males
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005744 Gastric Acid Hydrochloric acid present in GASTRIC JUICE. Hydrochloric Acid, Gastric,Acids, Gastric,Acids, Gastric Hydrochloric,Gastric Acids,Gastric Hydrochloric Acid,Gastric Hydrochloric Acids,Hydrochloric Acids, Gastric
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer

Related Publications

P Müller, and H G Dammann, and B Simon
April 1990, Alimentary pharmacology & therapeutics,
P Müller, and H G Dammann, and B Simon
December 1988, Alimentary pharmacology & therapeutics,
P Müller, and H G Dammann, and B Simon
January 1988, Gastroenterologie clinique et biologique,
P Müller, and H G Dammann, and B Simon
June 1988, Clinical and investigative medicine. Medecine clinique et experimentale,
P Müller, and H G Dammann, and B Simon
February 1983, Gut,
P Müller, and H G Dammann, and B Simon
February 1976, Gut,
P Müller, and H G Dammann, and B Simon
June 1993, Alimentary pharmacology & therapeutics,
Copied contents to your clipboard!